Kathleen Egan, ScD

Epidemiology and prevention of breast cancer and tumors of the brain

Associations

• Cancer Epidemiology
• Neuro-Oncology
• Cancer Epidemiology Program
• Melanoma & Skin Cancer Center of Excellence
• Cancer Chemoprevention Research Interest Group
• Cancer Epidemiology Program

Education & Training

Graduate:

• Harvard University, ScD
• Boston University, MPH

Dr. Egan is an epidemiologist with research interests in molecular epidemiology and lifestyle-directed prevention of cancer.  Over her career, she has published more than 240 primary research reports on breast and ovarian cancer risk factors and outcome, and etiologic and outcomes-focused research in melanoma and primary tumors of the brain. In the area of breast/ovarian cancer, she has published findings from the Nurses’ Health Study cohorts. She was also site PI for the ‘Collaborative Breast Cancer Study’ (CBCS), a multi-institutional, population-based case-control study of breast cancer that ultimately enrolled more than 20,000 breast cancer cases and 20,000 community controls. Ovarian cancer cases were also enrolled in one cycle of funding.  Based on 3 successive cycles of R01 funding, the CBCS is the basis for many original research studies focused on lifestyle risk factors in breast and ovarian cancer.  Dr. Egan also served as PI on a study examining genetic variants in the estrogen pathway based on the CBCS and she remains an active member of the Breast Cancer Association Consortium (BCAC) to which CBCS has made a considerable contribution. The large CBCS case cohort also offers new insights on lifestyle factors associated with breast cancer survival based on follow up of case women enrolled in the CBCS beginning in 1992.  Dr. Egan remains active in studies of breast cancer risk factors, with currently funded research examining the impact of gut microbial composition (the ‘gut microbiome’) on circulating estrogen levels and breast density in postmenopausal women.        Dr. Egan’s key area of active research is the elucidation of risk factors for primary tumors of the brain (glioma and meningioma). Glioma is one of the most devastating human tumors with a largely unknown etiology. Recognizing this knowledge gap, in 2005, Dr. Egan launched a multicenter case-control study to examine genetic and lifestyle risk factors for these tumors. Incident cases were enrolled at a network of high-volume academic medical centers in the Southeastern US. The infrastructure also provided opportunity to enroll patients with meningioma, a ‘benign’ tumor of the CNS, for etiologic research. More than 2000 glioma cases, 500 meningioma cases and 2000 community controls were enrolled in “GliomaSE”. Published findings pinpoint early life (higher birth order; delayed menarche; prolonged growth phase) as a critical period establishing risk of adult glioma. GliomaSE was also the first study to independently validate genetic risk associations from GWAS both for glioma and meningioma. Dr. Egan has also published novel findings linking viruses and other infectious agents with the risk of glioma based on the Janus Serum Bank and has prospectively investigated dietary factors in relation to glioma risk based on the Harvard cohort studies and UK Biobank.  Dr. Egan has also been active in etiologic and clinical/ translational research in melanoma. She has published more than 50 research articles on clinical outcomes in and risk factors for melanoma of the uveal tract, a rare and poorly understood tumor of the pigmented layer of the inner eye, based on the large clinic population at the Massachusetts Eye & Ear Infirmary, a major referral center for treatment of these tumors. 

Clinical Trial 21268
Biobanking for Breast Cancer Prevention and Disparity Research in Florida
Condition: Healthy Subjects
Status: Open

Clinical Trial 22605
Investigation of Microplastic Pollution in the Human Respiratory System and Its Relationship to Lung Cancer
Condition: Thoracic
Status: Open

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

• Yaghjyan L, Mai V, Darville LNF, Cline J, Wang X, Ukhanova M, Tagliamonte MS, Martinez YC, Rich SN, Koomen JM, Egan KM. Associations of gut microbiome with endogenous estrogen levels in healthy postmenopausal women. Cancer Causes Control. 2023 Oct.34(10):873-881. Pubmedid: 37286847.
• Mokhtari S, Peeri NC, Beer-Furlan A, Anderson MD, Chowdhary S, LaRocca RV, Mammoser AG, Nabors LB, Olson JJ, Thompson RC, Thompson ZJ, Martinez YC, Egan KM. Clinical and descriptive characteristics associated with high-grade meningioma in a large clinical series. Br J Neurosurg. 2023 Jun.1-4. Pubmedid: 37287223.
• Samanic CM, Teer JK, Thompson ZJ, Creed JH, Fridley BL, Burt Nabors L, Williams SL, Egan KM. Mitochondrial DNA sequence variation and risk of glioma. Mitochondrion. 2022 Mar.63:32-36. Pubmedid: 35032707. Pmcid: PMC8885975.
• Cote DJ, Stampfer MJ, Egan KM. Response to Letter to the Editor. Cancer Epidemiol. 2022 Jun.78:102126. Pubmedid: 35303619.
• Coghill AE, Kim Y, Hodge JM, Bender N, Smith-Warner SA, Teras LR, Grimsrud TK, Waterboer T, Egan KM. Prospective investigation of herpesvirus infection and risk of glioma. Int J Cancer. 2022 Jul.151(2):222-228. Pubmedid: 35225352.
• Yaghjyan L, Darville LNF, Cline J, Martinez YC, Rich S, Austin-Datta RJ, Koomen JM, Tworoger SS, Egan KM. Associations of established breast cancer risk factors with urinary estrogens in postmenopausal women. Cancer Causes Control. 2022 Feb.33(2):279-291. Pubmedid: 34988766.
• Samanic CM, Yue Y, Cote DJ, Stampfer MJ, Wang M, McCann A, Midttun Ø, Ueland PM, Smith-Warner SA, Egan KM. A prospective study of pre-diagnostic circulating tryptophan and kynurenine, and the kynurenine/tryptophan ratio and risk of glioma. Cancer Epidemiol. 2022 Feb.76:102075. Pubmedid: 34871928. Pmcid: PMC8855958.
• Samanic CM, Cote DJ, Creed JH, Stampfer MJ, Wang M, Smith-Warner SA, Egan KM. Prospective study of sleep duration and glioma risk. Cancer Causes Control. 2021 Sep.32(9):1039-1042. Pubmedid: 34014383. Pmcid: PMC8859696.
• Cote DJ, Samanic CM, Smith TR, Wang M, Smith-Warner SA, Stampfer MJ, Egan KM. Alcohol intake and risk of glioma: results from three prospective cohort studies. Eur J Epidemiol. 2021 Sep.36(9):965-974. Pubmedid: 34482513. Pmcid: PMC8859697.
• Egan KM, Kim Y, Bender N, Hodge JM, Coghill AE, Smith-Warner SA, Rollison DE, Teras LR, Grimsrud TK, Waterboer T. Prospective investigation of polyomavirus infection and the risk of adult glioma. Sci Rep. 2021 May.11(1):9642. Pubmedid: 33953301. Pmcid: PMC8100283.
• Yaghjyan L, Mai V, Wang X, Ukhanova M, Tagliamonte M, Martinez YC, Rich SN, Egan KM. Gut microbiome, body weight, and mammographic breast density in healthy postmenopausal women. Cancer Causes Control. 2021 Jul.32(7):681-692. Pubmedid: 33772705.
• Hodge JM, Coghill AE, Kim Y, Bender N, Smith-Warner SA, Gapstur S, Teras LR, Grimsrud TK, Waterboer T, Egan KM. Toxoplasma gondii infection and the risk of adult glioma in two prospective studies. Int J Cancer. 2021 Jan. Pubmedid: 33427315.
• Samanic CM, Teer JK, Thompson ZJ, Creed JH, Mokhtari S, Fridley BL, Nabors LB, Williams SL, Egan KM. Mitochondrial DNA sequence variation and risk of meningioma. J Neurooncol. 2021 Dec.155(3):319-324. Pubmedid: 34669147.
• Cote DJ, Creed JH, Samanic CM, Gerke TA, Stampfer MJ, Smith-Warner SA, Egan KM. A prospective study of inflammatory biomarkers and growth factors and risk of glioma in the UK Biobank. Cancer Epidemiol. 2021 Dec.75:102043. Pubmedid: 34564026. Pmcid: PMC8627477.
• Cote DJ, Smith-Warner SA, Creed JH, Furtado J, Gerke T, Wang M, Kim Y, Stampfer MJ, Egan KM. Circulating lipids and glioma risk: results from the UK Biobank, Nurses' Health Study, and Health Professionals Follow-Up Study. Cancer Causes Control. 2021 Apr.32(4):347-355. Pubmedid: 33484419. Pmcid: PMC8856012.
• Morra A, Jung AY, Behrens S, Keeman R, Ahearn TU, Anton-Cluver H, Arndt V, Augustinsson A, Auvinen PK, Beane Freeman LE, Becher H, Beckmann MW, Bloomqvist C, Bojesen SE, Bolla MK, Brenner H, Briceno I, Brucker SY, Camp NJ, Campa D, Canzian F, Castelao JE, Chanock SJ, Choi JY, Clarke CL, Couch FJ, Cox A, Cross SS, Czene K, Dӧrk T, Dunning AM, Dwek M, Easton DF, Eccles DM, Egan KM, Evans DG, Fasching PA, Flyger H, Gago-Dominguez M, Gapstur SM, Garcia-Saenz JA, Gaudet MM, Giles GG, Grip M, Guénel P, Haiman CA, Håkansson N, Hall P, Hamann U, Han SN, Hart SN, Hartman M, Heyworth JS, Hoppe R, Hopper JL, Hunter DJ, Ito H, Jager A, Jakimovska M, Jakubowska A, Janni W, Kaaks R, Kang D, Middha Kapoor P, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Lacey JV, Lambrechts D, Le Marchand L, Li J, Lindblom A, Lubiński J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Mariapun S, Matsuo K, Mavroudis D, Milne RL, Muranen TA, Newman WG, Noh DY, Nordestgaard BG, Obi N, Olshan AF, Olsson H, Park-Simon TW, Petridis C, Pharoah PDP, Plaseska-Karanfilska D, Presneau N, Rashid MU, Rennert G, Rennert HS, Rhenius V, Romero A, Saloustros E, Sawyer EJ, Schneeweiss A, Schwentner L, Scott CG, Shah M, Shen CY, Shu XO, Southey MC, Stram DO, Tamimi RM, Tapper W, Tollenaar RAEM, Tomlinson I, Torres D, Troester MA, Truong T, Vachon CM, Wang Q, Wang SS, Williams JA, Winqvist R, Wolk A, Wu AH, Yoo KY, Yu JC, Zheng W, Ziogas A, Yang XR, Eliassen AH, Holmes MD, Garcia-Closas M, Teo SH, Schmidt MK, Chang-Cla ...
• Yue Y, Creed JH, Cote DJ, Stampfer MJ, Wang M, Midttun Ø, McCann A, Ueland PM, Furtado J, Egan KM, Smith-Warner SA. Pre-diagnostic circulating concentrations of fat-soluble vitamins and risk of glioma in three cohort studies. Sci Rep. 2021 Apr.11(1):9318. Pubmedid: 33927267. Pmcid: PMC8084971.
• Mitchell JR, Kamnitsas K, Singleton KW, Whitmire SA, Clark-Swanson KR, Ranjbar S, Rickertsen CR, Johnston SK, Egan KM, Rollison DE, Arrington J, Krecke KN, Passe TJ, Verdoorn JT, Nagelschneider AA, Carr CM, Port JD, Patton A, Campeau NG, Liebo GB, Eckel LJ, Wood CP, Hunt CH, Vibhute P, Nelson KD, Hoxworth JM, Patel AC, Chong BW, Ross JS, Boxerman JL, Vogelbaum MA, Hu LS, Glocker B, Swanson KR. Deep neural network to locate and segment brain tumors outperformed the expert technicians who created the training data. J Med Imaging (Bellingham). 2020 Sep.7(5):055501. Pubmedid: 33102623. Pmcid: PMC7567400.
• Darville LNF, Cline JK, Rozmeski C, Martinez YC, Rich S, Eschrich SA, Egan KM, Yaghjyan L, Koomen JM. LC-HRMS of derivatized urinary estrogens and estrogen metabolites in postmenopausal women. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Oct.1154:122288. Pubmedid: 32769047. Pmcid: PMC7882395.
• Ogony JW, Radisky DC, Ruddy KJ, Goodison S, Wickland DP, Egan KM, Knutson KL, Asmann YW, Sherman ME. Immune Responses and Risk of Triple-negative Breast Cancer: Implications for Higher Rates among African American Women. Cancer Prev Res (Phila). 2020 Nov.13(11):901-910. Pubmedid: 32753376. Pmcid: PMC9576802.
• Whitmire P, Rickertsen CR, Hawkins-Daarud A, Carrasco E, Lorence J, De Leon G, Curtin L, Bayless S, Clark-Swanson K, Peeri NC, Corpuz C, Lewis-de Los Angeles CP, Bendok BR, Gonzalez-Cuyar L, Vora S, Mrugala MM, Hu LS, Wang L, Porter A, Kumthekar P, Johnston SK, Egan KM, Gatenby R, Canoll P, Rubin JB, Swanson KR. Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients. BMC Cancer. 2020 May.20(1):447. Pubmedid: 32429869. Pmcid: PMC7238585.
• Peeri NC, Egan KM, Chai W, Tao MH. Association of magnesium intake and vitamin D status with cognitive function in older adults: an analysis of US National Health and Nutrition Examination Survey (NHANES) 2011 to 2014. Eur J Nutr. 2020 May.60(1):465-474. Pubmedid: 32388734. Pmcid: PMC7649128.
• Ostrom QT, Egan KM, Nabors LB, Gerke T, Thompson RC, Olson JJ, La Rocca R, Chowdhary S, Eckel-Passow JE, Armstrong G, Wiencke JK, Bernstein JL, Claus EB, Il'yasova D, Johansen C, Lachance DH, Lai RK, Merrell RT, Olson SH, Sadetzki S, Schildkraut JM, Shete S, Houlston RS, Jenkins RB, Wrensch MR, Melin B, Amos CI, Huse JT, Barnholtz-Sloan JS, Bondy ML. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics. Int J Cancer. 2020 Feb.146(3):739-748. Pubmedid: 30963577. Pmcid: PMC6785354.
• Wijayabahu AT, Egan KM, Yaghjyan L. Uterine cancer in breast cancer survivors: a systematic review. Breast Cancer Res Treat. 2020 Feb.180(1):1-19. Pubmedid: 31897901.
• Creed JH, Smith-Warner SA, Gerke TA, Egan KM. A prospective study of coffee and tea consumption and the risk of glioma in the UK Biobank. Eur J Cancer. 2020 Apr.129:123-131. Pubmedid: 32151942.
• Cote DJ, Rosner BA, Smith-Warner SA, Egan KM, Stampfer MJ. Statin use, hyperlipidemia, and risk of glioma. Eur J Epidemiol. 2019 Sep.34(11):997-1011. Pubmedid: 31559554. Pmcid: PMC7206659.
• Reblin M, Sahebjam S, Peeri NC, Martinez YC, Thompson Z, Egan KM. Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida. J Palliat Med. 2019 Oct.22(10):1202-1207. Pubmedid: 31081711. Pmcid: PMC7364313.
• Howard R, Scheiner A, Kanetsky PA, Egan KM. Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratio. Ann Epidemiol. 2019 Oct.38:11-21.e6. Pubmedid: 31481293. Pmcid: PMC8653546.
• Yaghjyan L, Colditz G, Rosner B, Rich S, Egan K, Tamimi RM. Adolescent caffeine consumption and mammographic breast density in premenopausal women. Eur J Nutr. 2019 May.59(4):1633-1639. Pubmedid: 31152213. Pmcid: PMC6885099.
• Stringfield O, Arrington JA, Johnston SK, Rognin NG, Peeri NC, Balagurunathan Y, Jackson PR, Clark-Swanson KR, Swanson KR, Egan KM, Gatenby RA, Raghunand N. Multiparameter MRI Predictors of Long-Term Survival in Glioblastoma Multiforme. Tomography. 2019 Mar.5(1):135-144. Pubmedid: 30854451. Pmcid: PMC6403044.
• Poff A, Kourtnik A, Egan KM, Sahebjum S, D'Agostino D, Kumar NB. Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Semin Cancer Biol. 2019 Jun.56:135-148. Pubmedid: 29294371. Pmcid: PMC6927557.
• Peeri N, Egan K, Tao M. Association of Vitamin D and Magnesium Status with Cognitive Function in Older Adults: Results from the National Health and Nutrition Examination Survey (NHANES) 2011 to 2014 (FS05-03-19). Curr Dev Nutr. 2019 Jun.3(Suppl 1). Pmcid: PMC6579441.
• de Leede N, Bastiaannet E, van der Geest L, Egan K, van de Velde C, Balducci L, Bonsing B, Extermann M. An international comparison of treatment and short-term overall survival for older patients with pancreatic cancer. Geriatr Oncol. 2019 Jul.10(4):584-590. Pubmedid: 30799177.
• Creed JH, Peeri NC, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Brockman JD, Gerke TA, Nabors LB, Egan KM. Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma. Sci Rep. 2019 Jul.9(1):10861. Pubmedid: 31350461. Pmcid: PMC6659774.
• Howard R, Kanetsky PA, Egan KM. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer. Sci Rep. 2019 Dec.9(1):19673. Pubmedid: 31873162. Pmcid: PMC6928022.
• Johnston SK, Whitmire P, Massey SC, Kumthekar P, Porter AB, Raghunand N, Gonzalez-Cuyar LF, Mrugala MM, Hawkins-Daarud A, Jackson PR, Hu LS, Sarkaria JN, Wang L, Gatenby RA, Egan KM, Canoll P, Swanson KR. ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: A Multidisciplinary Team-based, Multifactorial Analytical Approach. Am J Clin Oncol. 2019 Aug.42(8):655-661. Pubmedid: 31343422. Pmcid: PMC7416695.
• Miller B, Peeri NC, Nabors LB, Creed JH, Thompson ZJ, Rozmeski CM, LaRocca RV, Chowdhary S, Olson JJ, Thompson RC, Egan KM. Handedness and the risk of glioma. J Neurooncol. 2018 May.137(3):639-644. Pubmedid: 29332185. Pmcid: PMC5924459.
• Yaghjyan L, Rich S, Mao L, Mai V, Egan KM. Interactions of coffee consumption and postmenopausal hormone use in relation to breast cancer risk in UK Biobank. Cancer Causes Control. 2018 Jun.29(6):519-525. Pubmedid: 29651651.
• Kowalski A, Striley CW, Varma DS, Egan KM, Yaghjyan L. Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival. J Breast Cancer. 2018 Jun.21(2):158-164. Pubmedid: 29963111. Pmcid: PMC6015986.
• Yaghjyan L, Wijayabahu AT, Egan KM. RE: The Association Between Dietary Quality and Overall and Cancer-Specific Mortality Among Cancer Survivors, NHANES III. JNCI Cancer Spectr. 2018 Jul.2(3):pky044. Pubmedid: 31361274. Pmcid: PMC6649830.
• Peeri NC, Creed JH, Anic GM, Thompson RC, Olson JJ, LaRocca RV, Chowdhary SA, Brockman JD, Gerke TA, Nabors LB, Egan KM. Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma. Cancer Epidemiol. 2018 Aug.55:45-51. Pubmedid: 29777993. Pmcid: PMC8845067.
• Cote DJ, Downer MK, Smith TR, Smith-Warner SA, Egan KM, Stampfer MJ. Height, waist circumference, body mass index, and body somatotype across the life course and risk of glioma. Cancer Causes Control. 2018 Aug.29(8):707-719. Pubmedid: 29943102. Pmcid: PMC6238636.
• Little RB, Burt Nabors L, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM. Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma. Cancer Causes Control. 2017 Jul.28(7):717-718. Pubmedid: 28455551.
• Little RB, Nabors LB, Olson JJ, Thompson ZJ, Rozmeski CM, LaRocca RV, Forsyth PA, Thompson RC, Oster RA, Chowdhary SA, Egan KM. Older age at the completion of linear growth is associated with an increased risk of adult glioma. Cancer Causes Control. 2017 Jul.28(7):709-716. Pubmedid: 28260177. Pmcid: PMC5469709.
• Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiol Biomarkers Prev. 2017 Dec.26(12):1753-1760. Pubmedid: 28986348. Pmcid: PMC5712247.
• Egan KM, Nabors LB, Thompson ZJ, Rozmeski CM, Anic GA, Olson JJ, LaRocca RV, Chowdhary SA, Forsyth PA, Thompson RC. Analgesic use and the risk of primary adult brain tumor. Eur J Epidemiol. 2016 Sep.31(9):917-925. Pubmedid: 26894804. Pmcid: PMC4991947.
• Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, Ahmed S, Aittomäki K, Andrulis IL, Anton-Culver H, Antonenkova NN, Arason A, Arndt V, Arun BK, Arver B, Bacot F, Barrowdale D, Baynes C, Beeghly-Fadiel A, Benitez J, Bermisheva M, Blomqvist C, Blot WJ, Bogdanova NV, Bojesen SE, Bonanni B, Borresen-Dale AL, Brand JS, Brauch H, Brennan P, Brenner H, Broeks A, Brüning T, Burwinkel B, Buys SS, Cai Q, Caldes T, Campbell I, Carpenter J, Chang-Claude J, Choi JY, Claes KB, Clarke C, Cox A, Cross SS, Czene K, Daly MB, de la Hoya M, De Leeneer K, Devilee P, Diez O, Domchek SM, Doody M, Dorfling CM, Dörk T, Dos-Santos-Silva I, Dumont M, Dwek M, Dworniczak B, Egan K, Eilber U, Einbeigi Z, Ejlertsen B, Ellis S, Frost D, Lalloo F, Fasching PA, Figueroa J, Flyger H, Friedlander M, Friedman E, Gambino G, Gao YT, Garber J, García-Closas M, Gehrig A, Damiola F, Lesueur F, Mazoyer S, Stoppa-Lyonnet D, Giles GG, Godwin AK, Goldgar DE, González-Neira A, Greene MH, Guénel P, Haeberle L, Haiman CA, Hallberg E, Hamann U, Hansen TV, Hart S, Hartikainen JM, Hartman M, Hassan N, Healey S, Hogervorst FB, Verhoef S, Hendricks CB, Hillemanns P, Hollestelle A, Hulick PJ, Hunter DJ, Imyanitov EN, Isaacs C, Ito H, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB, John EM, Joly Beauparlant C, Jones M, Kabisch M, Kang D, Karlan BY, Kauppila S, Kerin MJ, Khan S, Khusnutdinova E, Knight JA, Konst ...
• Doepker MP, Thompson ZJ, Harb JN, Messina JL, Puleo CA, Egan KM, Sarnaik AA, Gonzalez RJ, Sondak VK, Zager JS. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy. J Surg Oncol. 2016 Jan.113(1):98-102. Pubmedid: 26661407. Pmcid: PMC4904728.
• Passarelli MN, Newcomb PA, Hampton JM, Trentham-Dietz A, Titus LJ, Egan KM, Baron JA, Willett WC. Cigarette Smoking Before and After Breast Cancer Diagnosis: Mortality From Breast Cancer and Smoking-Related Diseases. J Clin Oncol. 2016 Apr.34(12):1315-1322. Pubmedid: 26811527. Pmcid: PMC4872346.
• Mulpur BH, Nabors LB, Thompson RC, Olson JJ, LaRocca RV, Thompson Z, Egan KM. Complementary therapy and survival in glioblastoma. Neurooncol Pract. 2015 Sep.2(3):122-126. Pubmedid: 26649185. Pmcid: PMC4671323.
• Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn GP, Smith T, Yue B, Diaz K, Chornokur G, Crocker T, Schell MJ. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prev Res (Phila). 2015 Oct.8(10):879-887. Pubmedid: 25873370. Pmcid: PMC4596745.
• Fair AM, Lewis TJ, Sanderson M, Dupont WD, Fletcher S, Egan KM, Disher AC. Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women. Nutr Res. 2015 Oct.35(10):851-857. Pubmedid: 26321093. Pmcid: PMC4579012.
• Baskin R, Woods NT, Mendoza-Fandiño G, Forsyth P, Egan KM, Monteiro AN. Functional analysis of the 11q23.3 glioma susceptibility locus implicates PHLDB1 and DDX6 in glioma susceptibility. Sci Rep. 2015 Nov.5:17367. Pubmedid: 26610392. Pmcid: PMC4661592.
• Owens MA, Craig BM, Egan KM, Reed DR. Birth desires and intentions of women diagnosed with a meningioma. J Neurosurg. 2015 May.122(5):1151-1156. Pubmedid: 25623387. Pmcid: PMC4524337.
• Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Czene K, Darabi H, Eriksson M, Peto J, Dos-Santos-Silva I, Dudbridge F, Johnson N, Schmidt MK, Broeks A, Verhoef S, Rutgers EJ, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, Figueroa J, Chanock SJ, Brinton L, Lissowska J, Couch FJ, Olson JE, Vachon C, Pankratz VS, Lambrechts D, Wildiers H, Van Ongeval C, van Limbergen E, Kristensen V, Grenaker Alnæs G, Nord S, Borresen-Dale AL, Nevanlinna H, Muranen TA, Aittomäki K, Blomqvist C, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Trentham-Dietz A, Newcomb P, Titus L, Egan KM, Hunter DJ, Lindstrom S, Tamimi RM, Kraft P, Rahman N, Turnbull C, Renwick A, Seal S, Li J, Liu J, Humphreys K, Benitez J, Pilar Zamora M, Arias Perez JI, Menéndez P, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Bogdanova NV, Antonenkova NN, Dörk T, Anton-Culver H, Neuhausen SL, Ziogas A, Bernstein L, Devilee P, Tollenaar RA, Seynaeve C, van Asperen CJ, Cox A, Cross SS, Reed MW, Khusnutdinova E, Bermisheva M, Prokofyeva D, Takhirova Z, Meindl A, Schmutzler RK, Sutter C, Yang R, Schürmann P, Bremer M, Christiansen H, Park-Simon TW, Hillemanns P, Guénel P, Truong T, Menegaux F, Sanchez M, Radice P, Peterlongo P, Manoukian S, Pensotti V, Hopper JL, Tsimiklis H, Apicella C, South ...
• Sprague BL, Gangnon RE, Hampton JM, Egan KM, Titus LJ, Kerlikowske K, Remington PL, Newcomb PA, Trentham-Dietz A. Variation in Breast Cancer-Risk Factor Associations by Method of Detection: Results From a Series of Case-Control Studies. Am J Epidemiol. 2015 Jun.181(12):956-969. Pubmedid: 25944893. Pmcid: PMC4462335.
• Egan KM, Baskin R, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Monteiro AN. Brain tumor risk according to germ-line variation in the MLLT10 locus. Eur J Hum Genet. 2015 Jan.23(1):132-134. Pubmedid: 24755950. Pmcid: PMC4266750.
• Schabath MB, Thompson ZJ, Egan KM, Torres BN, Nguyen A, Papenfuss MR, Abrahamsen ME, Giuliano AR. Alcohol consumption and prevalence of human papillomavirus (HPV) infection among US men in the HPV in Men (HIM) study. Sex Transm Infect. 2015 Feb.91(1):61-67. Pubmedid: 25278617. Pmcid: PMC4342055.
• Davies JR, Jewell R, Affleck P, Anic GM, Randerson-Moor J, Ozola A, Egan KM, Elliott F, García-Casado Z, Hansson J, Harland M, Höiom V, Jian G, Jönsson G, Kumar R, Nagore E, Wendt J, Olsson H, Park JY, Patel P, Pjanova D, Puig S, Schadendorf D, Rachakonda PS, Snowden H, Stratigos AJ, Bafaloukos D, Ogbah Z, Sucker A, Van den Oord JJ, Van Doorn R, Walker C, Okamoto I, Wolter P, Barrett JH, Bishop DT, Newton-Bishop J. Inherited variation in the PARP1 gene and survival from melanoma. Int J Cancer. 2014 Oct.135(7):1625-1633. Pubmedid: 24535833. Pmcid: PMC4106984.
• Trentham-Dietz A, Sprague BL, Hampton JM, Miglioretti DL, Nelson HD, Titus LJ, Egan KM, Remington PL, Newcomb PA. Modification of breast cancer risk according to age and menopausal status: a combined analysis of five population-based case-control studies. Breast Cancer Res Treat. 2014 May.145(1):165-175. Pubmedid: 24647890. Pmcid: PMC4112552.
• Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol. 2014 May.24(5):376-382. Pubmedid: 24792587. Pmcid: PMC4164346.
• Davies JR, Field S, Randerson-Moor J, Harland M, Kumar R, Anic GM, Nagore E, Hansson J, Höiom V, Jönsson G, Gruis NA, Park JY, Jian G, Rachakonda PS, Wendt J, Pjanova D, Puig S, Schadendorf D, Okamoto I, Olsson H, Affleck P, García-Casado Z, Puig-Butille JA, Stratigos AJ, Kodela E, Donina S, Sucker A, Hosen I, Egan KM, Barrett JH, van Doorn R, Bishop DT, Newton-Bishop J. An inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study. Pigment Cell Melanoma Res. 2014 Mar.27(2):234-243. Pubmedid: 24219834. Pmcid: PMC4065372.
• Anic GM, Madden MH, Nabors LB, Olson JJ, Larocca RV, Thompson ZJ, Pamnani SJ, Forsyth PA, Thompson RC, Egan KM. Reproductive factors and risk of primary brain tumors in women. J Neurooncol. 2014 Jun.118(2):297-304. Pubmedid: 24700240. Pmcid: PMC4048769.
• van de Water W, Bastiaannet E, Egan KM, de Craen AJ, Westendorp RG, Balducci L, van de Velde CJ, Liefers GJ, Extermann M. Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care. Geriatr Oncol. 2014 Jul.5(3):252-259. Pubmedid: 24661770. Pmcid: PMC4617765.
• Madden MH, Anic GM, Thompson RC, Nabors LB, Olson JJ, Browning JE, Monteiro AN, Egan KM. Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control. 2014 Jan.25(1):25-32. Pubmedid: 24135790. Pmcid: PMC3947318.
• Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Skinner HG, Engelman CD, Klein BE, Titus LJ, Egan KM, Newcomb PA. Breast cancer susceptibility loci in association with age at menarche, age at natural menopause and the reproductive lifespan. Cancer Epidemiol. 2014 Feb.38(1):62-65. Pubmedid: 24373701. Pmcid: PMC4023814.
• Owonikoko TK, Arbiser J, Zelnak A, Shu HK, Shim H, Robin AM, Kalkanis SN, Whitsett TG, Salhia B, Tran NL, Ryken T, Moore MK, Egan KM, Olson JJ. Current approaches to the treatment of metastatic brain tumours. Nat Rev Clin Oncol. 2014 Apr.11(4):203-222. Pubmedid: 24569448. Pmcid: PMC4041037.
• Anic GM, Madden MH, Sincich K, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Pan E, Egan KM. Early life exposures and the risk of adult glioma. Eur J Epidemiol. 2013 Sep.28(9):753-758. Pubmedid: 23681776. Pmcid: PMC3791322.
• Little RB, Madden MH, Thompson RC, Olson JJ, Larocca RV, Pan E, Browning JE, Egan KM, Nabors LB. Anthropometric factors in relation to risk of glioma. Cancer Causes Control. 2013 May.24(5):1025-1031. Pubmedid: 23456313. Pmcid: PMC3633685.
• Park JY, Amankwah EK, Anic GM, Lin HY, Walls B, Park H, Krebs K, Madden M, Maddox K, Marzban S, Fang S, Chen W, Lee JE, Wei Q, Amos CI, Messina JL, Sondak VK, Sellers TA, Egan KM. Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev. 2013 May.22(5):827-834. Pubmedid: 23462921. Pmcid: PMC3708315.
• Andersen SW, Trentham-Dietz A, Figueroa JD, Titus LJ, Cai Q, Long J, Hampton JM, Egan KM, Newcomb PA. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study. Menopause. 2013 Mar.20(3):354-358. Pubmedid: 23435034. Pmcid: PMC3549049.
• Newcomb PA, Kampman E, Trentham-Dietz A, Egan KM, Titus LJ, Baron JA, Hampton JM, Passarelli MN, Willett WC. Alcohol consumption before and after breast cancer diagnosis: associations with survival from breast cancer, cardiovascular disease, and other causes. J Clin Oncol. 2013 Jun.31(16):1939-1946. Pubmedid: 23569314. Pmcid: PMC3661933.
• Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, Fasching PA, Hopper JL, Makalic E, Schmidt DF, Southey MC, Beckmann MW, Ekici AB, Fletcher O, Gibson L, Silva Idos S, Peto J, Humphreys MK, Wang J, Cordina-Duverger E, Menegaux F, Nordestgaard BG, Bojesen SE, Lanng C, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Brauch H, Brüning T, Harth V, The Genica Network , Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Kconfab , Group AM, Lambrechts D, Smeets D, Neven P, Paridaens R, Flesch-Janys D, Obi N, Wang-Gohrke S, Couch FJ, Olson JE, Vachon CM, Giles GG, Severi G, Baglietto L, Offit K, John EM, Miron A, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Chanock SJ, Lissowska J, Liu J, Cox A, Cramp H, Connley D, Balasubramanian S, Dunning AM, Shah M, Trentham-Dietz A, Newcomb P, Titus L, Egan K, Cahoon EK, Rajaraman P, Sigurdson AJ, Doody MM, Guénel P, Pharoah PD, Schmidt MK, Hall P, Easton DF, Garcia-Closas M, Milne RL, Chang-Claude J. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013 Jun.9(3):e1003284. Pubmedid: 23544014. Pmcid: PMC3609648.
• Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquita HB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ...
• Anic GM, Madden MH, Thompson RC, Nabors LB, Olson JJ, Larocca RV, Browning JE, Brockman JD, Forsyth PA, Egan KM. Toenail iron, genetic determinants of iron status, and the risk of glioma. Cancer Causes Control. 2013 Dec.24(12):2051-2058. Pubmedid: 23996192. Pmcid: PMC3823695.
• Siegel EM, Nabors LB, Thompson RC, Olson JJ, Browning JE, Madden MH, Han G, Egan KM. Prediagnostic body weight and survival in high grade glioma. J Neurooncol. 2013 Aug.114(1):79-84. Pubmedid: 23666204. Pmcid: PMC3729798.
• Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM. SWI/SNF gene variants and glioma risk and outcome. Cancer Epidemiol. 2013 Apr.37(2):162-165. Pubmedid: 23276717. Pmcid: PMC3578123.
• Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Res. 2013.15(5):R99. Pubmedid: 24152546. Pmcid: PMC3978665.
• Anic GM, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Reed Murtagh F, Forsyth PA, Egan KM. An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome. Cancer Causes Control. 2012 Sep.23(9):1443-1449. Pubmedid: 22740028. Pmcid: PMC3563063.
• Higginbotham KS, Breyer JP, McReynolds KM, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Parl FF, Sanders ME, Page DL, Egan KM, Dupont WD, Smith JR. A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24. Cancer Epidemiol Biomarkers Prev. 2012 Sep.21(9):1565-1573. Pubmedid: 22806168. Pmcid: PMC3707501.
• Egan KM, Wrensch MR, Jenkins RB. Rare and uncommon genetic variants may hold key to the 'missing heritability' in glioma. CNS Oncol. 2012 Nov.1(2):109-112. Pubmedid: 25057857. Pmcid: PMC6176832.
• Kumar N, Crocker T, Smith T, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Slaton J, Anderson JK. Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012 Mar.33(2):279-285. Pubmedid: 22101219. Pmcid: PMC3268882.
• Kumar NB, Vadaparampil ST, Mahajan N, Lilienfeld HS, Lee JH, Laronga C, Hakam A, Hein JJ, Egan KM, Arun B, Pal T. Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers. Hereditary Genet. 2012 Jun.1(2). Pubmedid: 26097796. Pmcid: PMC4474476.
• Mocellin S, Verdi D, Pooley KA, Landi MT, Egan KM, Baird DM, Prescott J, De Vivo I, Nitti D. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst. 2012 Jun.104(11):840-854. Pubmedid: 22523397. Pmcid: PMC3611810.
• Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, O'Neill BP, Buckner JC, Thompson RC, Nabors LB, Olson JJ, Brem S, Madden MH, Browning JE, Wiencke JK, Egan KM, Jenkins RB, Wrensch MR. SSBP2 variants are associated with survival in glioblastoma patients. Clin Cancer Res. 2012 Jun.18(11):3154-3162. Pubmedid: 22472174. Pmcid: PMC3607457.
• Egan KM, Nabors LB, Olson JJ, Monteiro AN, Browning JE, Madden MH, Thompson RC. Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet. 2012 Jul.49(7):420-421. Pubmedid: 22706378. Pmcid: PMC3576847.
• Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, Trabulsi E, McLarty J, Fazili T, Williams CR, Schreiber F, Anderson K. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. J Clin Trials. 2012 Jan.2(1). Pubmedid: 24533253. Pmcid: PMC3924733.
• Hein R, Maranian M, Hopper JL, Kapuscinski MK, Southey MC, Park DJ, Schmidt MK, Broeks A, Hogervorst FB, Bueno-de-Mesquit HB, Muir KR, Lophatananon A, Rattanamongkongul S, Puttawibul P, Fasching PA, Hein A, Ekici AB, Beckmann MW, Fletcher O, Johnson N, Dos Santos Silva I, Peto J, Sawyer E, Tomlinson I, Kerin M, Miller N, Marmee F, Schneeweiss A, Sohn C, Burwinkel B, Guénel P, Cordina-Duverger E, Menegaux F, Truong T, Bojesen SE, Nordestgaard BG, Flyger H, Milne RL, Perez JI, Zamora MP, Benítez J, Anton-Culver H, Ziogas A, Bernstein L, Clarke CA, Brenner H, Müller H, Arndt V, Stegmaier C, Rahman N, Seal S, Turnbull C, Renwick A, Meindl A, Schott S, Bartram CR, Schmutzler RK, Brauch H, Hamann U, Ko YD, Wang-Gohrke S, Dörk T, Schürmann P, Karstens JH, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova NV, Zalutsky IV, Antonenkova NN, Bermisheva M, Prokovieva D, Farahtdinova A, Khusnutdinova E, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen J, Chen X, Beesley J, Investigators K, Lambrechts D, Zhao H, Neven P, Wildiers H, Nickels S, Flesch-Janys D, Radice P, Peterlongo P, Manoukian S, Barile M, Couch FJ, Olson JE, Wang X, Fredericksen Z, Giles GG, Baglietto L, McLean CA, Severi G, Offit K, Robson M, Gaudet MM, Vijai J, Alnæs GG, Kristensen V, Børresen-Dale AL, John EM, Miron A, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Figueroa JD, García-Closas M, Lissowska J, Sherman ME, ...
• Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Chen YA. Erratum to: Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep.104(2):543. Pubmedid: 21286782.
• Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y. Cancer susceptibility variants and the risk of adult glioma in a US case-control study. J Neurooncol. 2011 Sep.104(2):535-542. Pubmedid: 21203894. Pmcid: PMC3138895.
• Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery?. Am J Epidemiol. 2011 May.173(10):1111-1120. Pubmedid: 21430192. Pmcid: PMC3105288.
• Newcomb PA, Trentham-Dietz A, Hampton JM, Egan KM, Titus-Ernstoff L, Warren Andersen S, Greenberg ER, Willett WC. Late age at first full term birth is strongly associated with lobular breast cancer. Cancer. 2011 May.117(9):1946-1956. Pubmedid: 21509772. Pmcid: PMC3117094.
• Higginbotham KS, Breyer JP, Bradley KM, Schuyler PA, Plummer WD, Freudenthal ME, Trentham-Dietz A, Newcomb PA, Sanders ME, Page DL, Parl FF, Egan KM, Dupont WD, Smith JR. A multistage association study identifies a breast cancer genetic locus at NCOA7. Cancer Res. 2011 Jun.71(11):3881-3888. Pubmedid: 21610108. Pmcid: PMC3137260.
• Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Bersch AJ, Passarelli MN, Holick CN, Titus-Ernstoff L, Egan KM, Holmes MD, Willett WC. Post-diagnosis dietary factors and survival after invasive breast cancer. Breast Cancer Res Treat. 2011 Jul.128(1):229-236. Pubmedid: 21197569. Pmcid: PMC3201727.
• Heine JJ, Land WH, Egan KM. Statistical learning techniques applied to epidemiology: a simulated case-control comparison study with logistic regression. BMC Bioinformatics. 2011 Jan.12:37. Pubmedid: 21272346. Pmcid: PMC3045299.
• Cai Q, Wen W, Qu S, Li G, Egan KM, Chen K, Deming SL, Shen H, Shen CY, Gammon MD, Blot WJ, Matsuo K, Haiman CA, Khoo US, Iwasaki M, Santella RM, Zhang L, Fair AM, Hu Z, Wu PE, Signorello LB, Titus-Ernstoff L, Tajima K, Henderson BE, Chan KY, Kasuga Y, Newcomb PA, Zheng H, Cui Y, Wang F, Shieh YL, Iwata H, Le Marchand L, Chan SY, Shrubsole MJ, Trentham-Dietz A, Tsugane S, Garcia-Closas M, Long J, Li C, Shi J, Huang B, Xiang YB, Gao YT, Lu W, Shu XO, Zheng W. Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res. 2011 Feb.71(4):1344-1355. Pubmedid: 21303983. Pmcid: PMC3083305.
• Permuth-Wey J, Thompson RC, Burton Nabors L, Olson JJ, Browning JE, Madden MH, Ann Chen Y, Egan KM. A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma. J Neurooncol. 2011 Dec.105(3):639-646. Pubmedid: 21744077. Pmcid: PMC3217154.
• Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, Strick R, Peto J, dos Santos Silva I, Fletcher O, Johnson N, Sawyer E, Tomlinson I, Kerin M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Bojesen S, Flyger H, Nordestgaard BG, Benítez J, Milne RL, Ignacio Arias J, Zamora MP, Brenner H, Müller H, Arndt V, Rahman N, Turnbull C, Seal S, Renwick A, Brauch H, Justenhoven C, Brüning T, Chang-Claude J, Hein R, Wang-Gohrke S, Dörk T, Schürmann P, Bremer M, Hillemanns P, Nevanlinna H, Heikkinen T, Aittomäki K, Blomqvist C, Bogdanova N, Antonenkova N, Rogov YI, Karstens JH, Bermisheva M, Prokofieva D, Gantcev SH, Khusnutdinova E, Lindblom A, Margolin S, Chenevix-Trench G, Beesley J, Chen X, Mannermaa A, Kosma VM, Soini Y, Kataja V, Lambrechts D, Yesilyurt BT, Chrisiaens MR, Peeters S, Radice P, Peterlongo P, Manoukian S, Barile M, Couch F, Lee AM, Diasio R, Wang X, Giles GG, Severi G, Baglietto L, Maclean C, Offit K, Robson M, Joseph V, Gaudet M, John EM, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Andrulis I, Knight JA, Mulligan AM, O'Malley FP, Brinton LA, Sherman ME, Lissowska J, Chanock SJ, Hooning M, Martens JW, van den Ouweland AM, Collée JM, Hall P, Czene K, Cox A, Brock IW, Reed MW, Cross SS, Pharoah P, Dunning AM, Kang D, Yoo KY, Noh DY, Ahn SH, Jakubowska A, Lubinski J, Jaworska K, Durda K, Sangrajrang S, Gaborieau V, Brennan P, McKa ...
• Warren Andersen S, Newcomb PA, Hampton JM, Titus-Ernstoff L, Egan KM, Trentham-Dietz A. Reproductive factors and histologic subtype in relation to mortality after a breast cancer diagnosis. Breast Cancer Res Treat. 2011 Dec.130(3):975-980. Pubmedid: 21769659. Pmcid: PMC4306414.
• Anic GM, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Egan KM. Sleep duration and obesity in a population-based study. Sleep Med. 2010 May.11(5):447-451. Pubmedid: 20363668. Pmcid: PMC2854876.
• Peterson NB, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Huang Y, Chanock SJ, Haines JL, Egan KM. Association of COMT haplotypes and breast cancer risk in caucasian women. Anticancer Res. 2010 Jan.30(1):217-220. Pubmedid: 20150638. Pmcid: PMC3086748.
• Fair AM, Wujcik D, Lin JM, Zheng W, Egan KM, Grau AM, Champion VL, Wallston KA. Psychosocial determinants of mammography follow-up after receipt of abnormal mammography results in medically underserved women. J Health Care Poor Underserved. 2010 Feb.21(1 Suppl):71-94. Pubmedid: 20173286. Pmcid: PMC2927817.
• Lewis TJ, Dupont WD, Egan KM, Jones CD, Disher AC, Riddle WR, Fair AM. The "Got D'ViBE?" study: an inter-institutional project assessing vitamin D and mammographic breast density. J Health Care Poor Underserved. 2010 Feb.21(1 Suppl):17-25. Pubmedid: 20173282. Pmcid: PMC2930256.
• Beasley JM, Newcomb PA, Trentham-Dietz A, Hampton JM, Ceballos RM, Titus-Ernstoff L, Egan KM, Holmes MD. Social networks and survival after breast cancer diagnosis. J Cancer Surviv. 2010 Dec.4(4):372-380. Pubmedid: 20652435. Pmcid: PMC2978785.
• Lane AM, Egan KM, Kim IK, Gragoudas ES. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug.128(8):996-1000. Pubmedid: 20696999.
• Kim IK, Lane AM, Egan KM, Munzenrider J, Gragoudas ES. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug.117(8):1617-1622. Pubmedid: 20363507.
• Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: results from a systematic review and meta-analysis. Familial Cancer. 2009 Sep.8(2):109-117. Pubmedid: 18763055.
• Wise LA, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Trichopoulos D, Hampton JM, Egan KM. Exposure to breast milk in infancy and risk of breast cancer. Cancer Causes Control. 2009 Sep.20(7):1083-1090. Pubmedid: 19330531. Pmcid: PMC3152199.
• Lane AM, Egan KM, Harmon D, Holbrook A, Munzenrider JE, Gragoudas ES. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov.116(11):2206-2212. Pubmedid: 19744725.
• Nichols HB, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Holmes MD, Bersch AJ, Holick CN, Hampton JM, Stampfer MJ, Willett WC, Newcomb PA. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol Biomarkers Prev. 2009 May.18(5):1403-1409. Pubmedid: 19366908. Pmcid: PMC2715918.
• Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kämpjärvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schürmann P, Dörk T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M. Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev. 2009 May.18(5) ...
• Parl FF, Egan KM, Li C, Crooke PS. Estrogen exposure, metabolism, and enzyme variants in a model for breast cancer risk prediction. Cancer Inform. 2009 May.7:109-121. Pubmedid: 19718449. Pmcid: PMC2730178.
• Newcomb PA, Nichols HB, Beasley JM, Egan K, Titus-Ernstoff L, Hampton JM, Trentham-Dietz A. No difference between red wine or white wine consumption and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 Mar.18(3):1007-1010. Pubmedid: 19273487. Pmcid: PMC2710299.
• Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Willett WC, Egan KM. Dietary carotenoids and the risk of invasive breast cancer. Int J Cancer. 2009 Jun.124(12):2929-2937. Pubmedid: 19330841. Pmcid: PMC3564658.
• Egan KM. Vitamin D and melanoma. Ann Epidemiol. 2009 Jul.19(7):455-461. Pubmedid: 19282200.
• Fair AM, Wujcik D, Lin JM, Grau A, Wilson V, Champion V, Zheng W, Egan KM. Obesity, gynecological factors, and abnormal mammography follow-up in minority and medically underserved women. J Womens Health (Larchmt). 2009 Jul.18(7):1033-1039. Pubmedid: 19558307. Pmcid: PMC2851132.
• Kumar N, Titus-Ernstoff L, Newcomb PA, Trentham-Dietz A, Anic G, Egan KM. Tea consumption and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2009 Jan.18(1):341-345. Pubmedid: 19124518. Pmcid: PMC3156033.
• Ahern TP, Lash TL, Egan KM, Baron JA. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes Control. 2009 Dec.20(10):1837-1844. Pubmedid: 19533391.
• Huang Y, Trentham-Dietz A, García-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM. Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women. Cancer Epidemiol Biomarkers Prev. 2009 Apr.18(4):1321-1323. Pubmedid: 19293312. Pmcid: PMC2692636.
• Mignone LI, Giovannucci E, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Orav EJ, Willett WC, Egan KM. Meat consumption, heterocyclic amines, NAT2, and the risk of breast cancer. Nutr Cancer. 2009.61(1):36-46. Pubmedid: 19116874. Pmcid: PMC4902008.
• Peterson NB, Huang Y, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Anic G, Egan KM. Childbearing recency and modifiers of premenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2008 Nov.17(11):3284-3287. Pubmedid: 18990773. Pmcid: PMC2674789.
• Egan K, Signorello L, Munro H, Hargreaves M, Hollis B, Blot W. Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control. 2008 Jun.19(5):527-535. Pubmedid: 18219582.
• Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Brit J Cancer. 2008 Jun.98(11):1781-1783. Pubmedid: 18506182. Pmcid: PMC2410126.
• Fair AM, Wujcik D, Lin JM, Egan KM, Grau AM, Zheng W. Timing is everything: methodologic issues locating and recruiting medically underserved women for abnormal mammography follow-up research. Contemp Clin Trials. 2008 Jul.29(4):537-546. Pubmedid: 18289943. Pmcid: PMC2483696.
• Pocobelli G, Newcomb PA, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Egan KM. Statin use and risk of breast cancer. Cancer. 2008 Jan.112(1):27-33. Pubmedid: 18008366.
• Holick C, Newcomb P, Trentham-Dietz A, Titus-Ernstoff L, Bersch A, Stampfer M, Baron J, Egan K, Willett W. Physical activity and survival after diagnosis of invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Feb.17(2):379-386. Pubmedid: 18250341.
• Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM. Hormone therapy and ovarian cancer: incidence and survival. Cancer Causes Control. 2008 Aug.19(6):605-613. Pubmedid: 18264784. Pmcid: PMC2729759.
• Sprague BL, Trentham-Dietz A, Egan KM, Titus-Ernstoff L, Hampton JM, Newcomb PA. Proportion of invasive breast cancer attributable to risk factors modifiable after menopause. Am J Epidemiol. 2008 Aug.168(4):404-411. Pubmedid: 18552361. Pmcid: PMC2727276.
• Cai H, Shu XO, Egan KM, Cai Q, Long JR, Gao YT, Zheng W. Association of genetic polymorphisms in CYP19A1 and blood levels of sex hormones among postmenopausal Chinese women. Pharmacogenet Genomics. 2008 Aug.18(8):657-664. Pubmedid: 18622258. Pmcid: PMC2613759.
• Newcomb PA, Egan KM, Trentham-Dietz A, Titus-Ernstoff L, Baron JA, Hampton JM, Stampfer MJ, Willett WC. Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol Biomarkers Prev. 2008 Apr.17(4):864-871. Pubmedid: 18381475. Pmcid: PMC2780320.
• Trentham-Dietz A, Nichols H, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Cigarette Smoking and Risk of Breast Carcinoma In Situ. Epidemiology. 2007 Sep.18(5):629-638. Pubmedid: 17700252.
• Nichols H, Trentham-Dietz A, Egan K, Titus-Ernstoff L, Hampton J, NewcombPA. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Epidemiol Biomarkers Prev. 2007 Nov.16(11):2262-2268. Pubmedid: 18006914.
• Gaudet M, Egan K, Lissowska J, Newcomb P, Brinton L, Titus-Ernstoff L, Yeager M, Chanock S, Welch R, Peplonska B, Trentham-Dietz A, Garcia-Closas M. Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet. 2007 May.121(3-4):483-490. Pubmedid: 17216494.
• McElroy J, Egan K, Titus-Ernstoff L, Anderson H, Trentham-Dietz A, Hampton J, Newcomb P. Occupational exposure to electromagnetic field and breast cancer risk in a large, population-based, case-control study in the United States. J Occup Environ Med. 2007 Mar.49(3):266-274. Pubmedid: 17351512.
• Sprague B, Trentham-Dietz A, Newcomb P, Titus-Ernstoff L, Hampton J, Egan K. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Feb.16(2):236-243. Pubmedid: 17301255.
• Sprague B, Trentham-Dietz A, Garcia-Closas M, Newcomb P, Titus-Ernstoff L, Hampton J, Chanock S, Haines J, Egan K. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis. 2007 Aug.28(8):1680-1686. Pubmedid: 17449902.
• Liang X, Trentham-Dietz A, Titus-Ernstoff L, Newcomb P, Welch R, HutchinsonAA, Hampton J, Sutcliffe C, Haines J, Egan K. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer. Cancer Epidemiol Biomarkers Prev. 2007 Aug.16(8):1610-1614. Pubmedid: 17684135.
• Yasui Y, Newcomb P, Trentham-Dietz A, Egan K. Familial relative risk estimates for use in epidemiologic analyses. Am J Epidemiol. 2006 Oct.164(7):697-705. Pubmedid: 16923773.
• Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Hampton J, Willett W, Egan K. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer. 2006 Nov.119(10):2423-2427. Pubmedid: 16921486.
• Nichols H, Trentham-Dietz A, Hampton J, Titus-Ernstoff L, Egan K, WillettWC, Newcomb P. From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol. 2006 Nov.164(10):1003-1011. Pubmedid: 16928728.
• Peterson N, Trentham-Dietz A, Newcomb P, Chen Z, Gebretsadik T, HamptonJM, Stampfer M, Willett W, Egan K. Relation of anthropometric measurements to ovarian cancer risk in a population-based case-control study (United States). Cancer Causes Control. 2006 May.17(4):459-467. Pubmedid: 16596298.
• Garcia-Closas M, Egan K, Newcomb P, Brinton L, Titus-Ernstoff L, ChanockS, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak A, Struewing J. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet. 2006 May.119(4):376-388. Pubmedid: 16485136.
• Marucci L, Lane A, Li W, Egan K, Gragoudas E, Adams J, Collier J, Munzenrider J. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar.64(4):1018-1022. Pubmedid: 16376492.
• Newcomb P, Egan K. Dairy food and ovarian cancer risk. Lancet. 2006 Mar.367(9513):797-799. Pubmedid: 16530561.
• Zhang Y, Newcomb P, Egan K, Titus-Ernstoff L, Chanock S, Welch R, BrintonLA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2006 Feb.15(2):353-358. Pubmedid: 16492928.
• Long J, Egan K, Dunning L, Shu X, Cai Q, Cai H, Dai Q, Holtzman J, GaoYT, Zheng W. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics. 2006 Apr.16(4):237-243. Pubmedid: 16538170.
• Egan K. Commentary: sunlight, vitamin D, and the cancer connection revisited. Int J Epidemiol. 2006 Apr.35(2):227-30. Pubmedid: 16303801.
• Salmon JR, Kwak J, Acquaviva KD, Egan KA, Brandt K. Validation of the caregiving at life's end questionnaire. Am J Hosp Palliat Care. 2005 May.22(3):188-194. Pubmedid: 15909781.
• Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation. 2005 Jan.111(3):334-342. Pubmedid: 15655126.
• Egan KM, Sosman JA, Blot WJ. Sunlight and reduced risk of cancer: is the real story vitamin D?. J Natl Cancer Inst. 2005 Feb.97(3):161-163. Pubmedid: 15687354.
• Roscoe L, Egan K, Schonwetter R. Creating an academic-community provider partnership in hospice, palliative care, and end-of-life studies. Cancer Control. 2004 Nov.11(6):397-403. Pubmedid: 15625527.
• Egan KM, Newcomb PA, Ambrosone CB, Trentham-Dietz A, Titus-Ernstoff L, Hampton JM, Kimura MT, Nagase H. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis. 2004 Nov.25(11):2149-2153. Pubmedid: 15271853.
• Kang JH, Pasquale LR, Willett WC, Rosner BA, Egan KM, Faberowski N, Hankinson SE. Dietary fat consumption and primary open-angle glaucoma. Am J Clin Nutr. 2004 May.79(5):755-764. Pubmedid: 15113712.
• Egan KM, Thompson PA, Titus-Ernstoff L, Moore JH, Ambrosone CB. MnSOD polymorphism and breast cancer in a population-based case-control study. Cancer Lett. 2003 Sep.199(1):27-33. Pubmedid: 12963120.
• Leong NM, Mignone LI, Newcomb PA, Titus-Ernstoff L, Baron JA, Trentham-Dietz A, Stampfer MJ, Willett WC, Egan KM. Early life risk factors in cancer: the relation of birth weight to adult obesity. Int J Cancer. 2003 Mar.103(6):789-791. Pubmedid: 12516100.
• Fung TT, Spiegelman D, Egan KM, Giovannucci E, Hunter DJ, Willett WC. Vitamin and carotenoid intake and risk of squamous cell carcinoma of the skin. Int J Cancer. 2003 Jan.103(1):110-115. Pubmedid: 12455062.
• Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. Arch Ophthalmol. 2003 Jan.121(1):68-72. Pubmedid: 12523887.
• Arroyo JG, Postel EA, Stone T, McCuen BW, Egan KM. A matched study of primary scleral buckle placement during repair of posterior segment open globe injuries. Br J Ophthalmol. 2003 Jan.87(1):75-78. Pubmedid: 12488267. Pmcid: PMC1771464.
• Egan KM, Newcomb PA, Titus-Ernstoff L, Trentham-Dietz A, Mignone LI, Farin F, Hunter DJ. Association of NAT2 and smoking in relation to breast cancer incidence in a population-based case-control study (United States). Cancer Causes Control. 2003 Feb.14(1):43-51. Pubmedid: 12708724.
• Kang JH, Pasquale LR, Rosner BA, Willett WC, Egan KM, Faberowski N, Hankinson SE. Prospective study of cigarette smoking and the risk of primary open-angle glaucoma. Arch Ophthalmol. 2003 Dec.121(12):1762-1768. Pubmedid: 14662597.
• Kang JH, Pasquale LR, Willett W, Rosner B, Egan KM, Faberowski N, Hankinson SE. Antioxidant intake and primary open-angle glaucoma: a prospective study. Am J Epidemiol. 2003 Aug.158(4):337-346. Pubmedid: 12915499.
• Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Nov.11(11):1503-1504. Pubmedid: 12433736.
• Bertone ER, Newcomb PA, Willett WC, Stampfer MJ, Egan KM. Recreational physical activity and ovarian cancer in a population-based case-control study. Int J Cancer. 2002 May.99(3):431-436. Pubmedid: 11992414.
• Newcomb PA, Titus-Ernstoff L, Egan KM, Trentham-Dietz A, Baron JA, Storer BE, Willett WC, Stampfer MJ. Postmenopausal estrogen and progestin use in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2002 Jul.11(7):593-600. Pubmedid: 12101105.
• Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002 Dec.120(12):1665-1671. Pubmedid: 12470140.
• Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002.100:43-48. Pubmedid: 12545676. Pmcid: PMC1358945.
• McElroy JA, Newcomb PA, Remington PL, Egan KM, Titus-Ernstoff L, Trentham-Dietz A, Hampton JM, Baron JA, Stampfer MJ, Willett WC. Electric blanket or mattress cover use and breast cancer incidence in women 50-79 years of age. Epidemiology. 2001 Nov.12(6):613-617. Pubmedid: 11679786.
• García-Closas M, Egan KM, Abruzzo J, Newcomb PA, Titus-Ernstoff L, Franklin T, Bender PK, Beck JC, Le Marchand L, Lum A, Alavanja M, Hayes RB, Rutter J, Buetow K, Brinton LA, Rothman N. Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev. 2001 Jun.10(6):687-696. Pubmedid: 11401920.
• Bertone ER, Hankinson SE, Newcomb PA, Rosner B, Willet WC, Stampfer MJ, Egan KM. A population-based case-control study of carotenoid and vitamin A intake and ovarian cancer (United States). Cancer Causes Control. 2001 Jan.12(1):83-90. Pubmedid: 11227928.
• Gragoudas ES, Lane AM, Regan S, Li W, Judge HE, Munzenrider JE, Seddon JM, Egan KM. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun.118(6):773-778. Pubmedid: 10865313.
• Trentham-Dietz A, Newcomb PA, Egan KM, Titus-Ernstoff L, Baron JA, Storer BE, Stampfer M, Willett WC. Weight change and risk of postmenopausal breast cancer (United States). Cancer Causes Control. 2000 Jul.11(6):533-542. Pubmedid: 10880035.
• Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol. 2000 Aug.118(8):1066-1070. Pubmedid: 10922199.
• Regan S, Judge HE, Gragoudas ES, Egan KM. Iris color as a prognostic factor in ocular melanoma. Arch Ophthalmol. 1999 Jun.117(6):811-814. Pubmedid: 10369595.
• Egan KM, Quinn JL, Gragoudas ES. Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol. 1999 Jul.117(7):939-942. Pubmedid: 10408460.
• Sinilnikova OM, Egan KM, Quinn JL, Boutrand L, Lenoir GM, Stoppa-Lyonnet D, Desjardins L, Levy C, Goldgar D, Gragoudas ES. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 1999 Jul.82(3):325-328. Pubmedid: 10399947.
• Egan KM, Giovannucci E. Dietary mutagens and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov.90(22):1687-1689. Pubmedid: 9827516.
• Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-dependent covariates. Arch Ophthalmol. 1998 Mar.116(3):366-370. Pubmedid: 9514491.
• Egan KM, Newcomb PA, Longnecker MP, Trentham-Dietz A, Baron JA, Trichopoulos D, Stampfer MJ, Willett WC. Jewish religion and risk of breast cancer. Lancet. 1996 Jun.347(9016):1645-1646. Pubmedid: 8642956.
• Egan KM, Stampfer MJ, Giovannucci E, Rosner BA, Colditz GA. Prospective study of regular aspirin use and the risk of breast cancer. J Natl Cancer Inst. 1996 Jul.88(14):988-993. Pubmedid: 8667430.
• Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res. 1996 Dec.6(6):405-410. Pubmedid: 9013477.
• Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, Speizer FE. Aspirin and the risk of colorectal cancer in women. N Engl J Med. 1995 Sep.333(10):609-614. Pubmedid: 7637720.
• Gragoudas ES, Egan KM, Walsh SM, Regan S, Munzenrider JE, Taratuta V. Lens changes after proton beam irradiation for uveal melanoma. Am J Ophthalmol. 1995 Feb.119(2):157-164. Pubmedid: 7832221.
• Young LH, Egan KM, Walsh SM, Gragoudas ES. Familial uveal melanoma. Am J Ophthalmol. 1994 Apr.117(4):516-520. Pubmedid: 8154536.
• Colditz GA, Egan KM, Stampfer MJ. Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies. Am J Obstet Gynecol. 1993 May.168(5):1473-1480. Pubmedid: 8498430.
• Marcus DM, Mawn LA, Egan KM, Albert DM. Nucleolar organizer regions in iris nevi and melanomas. Am J Ophthalmol. 1992 Aug.114(2):202-207. Pubmedid: 1642296.
• Saornil MA, Egan KM, Gragoudas ES, Seddon JM, Walsh SM, Albert DM. Histopathology of proton beam-irradiated vs enucleated uveal melanomas. Arch Ophthalmol. 1992 Aug.110(8):1112-1118. Pubmedid: 1323252.
• Gragoudas ES, Egan KM, Arrigg PG, Seddon JM, Glynn RJ, Munzenrider JE. Cataract extraction after proton beam irradiation for malignant melanoma of the eye. Arch Ophthalmol. 1992 Apr.110(4):475-479. Pubmedid: 1562251.
• Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991 Mar.98(3):383-389. Pubmedid: 2023760.
• Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma. A case-control study. Arch Ophthalmol. 1990 Sep.108(9):1274-1280. Pubmedid: 2400347.
• Bitter GA, Egan KM. Expression of interferon-gamma from hybrid yeast GPD promoters containing upstream regulatory sequences from the GAL1-GAL10 intergenic region. Gene. 1988 Sep.69(2):193-207. Pubmedid: 2853097.
• Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988 Jan.32(4):239-251. Pubmedid: 3279559.
• Ormerod LD, Egan KM. Spontaneous hyphaema and corneal haemorrhage as complications of microbial keratitis. Br J Ophthalmol. 1987 Dec.71(12):933-937. Pubmedid: 3427003. Pmcid: PMC1041348.
• Seddon JM, Polivogianis L, Gragoudas ES, Hsieh CC, Egan KM. Enucleation vs cobalt 60 irradiation of melanomas. Arch Ophthalmol. 1986 Feb.104(2):175-176. Pubmedid: 3947285.

• Title: Biobanking for Breast Cancer Prevention and Disparity Research in Florida
  Sponsor: Florida Biomedical Research Program (FBRP)
  PI: Egan, K.